Can modern Radiotherapy's late effects be predicted?
NCT ID NCT04746729
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study follows a large group of children and young adults who received radiation therapy for cancer, to see how their health and quality of life evolve over many years. By collecting medical data and blood samples in a European registry, researchers aim to identify late effects such as heart problems, hormone issues, and new cancers. The goal is to better understand the long-term risks of modern radiotherapy and improve follow-up care for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This research could help doctors understand the long-term health and quality-of-life effects of modern radiotherapy in children, potentially guiding safer treatment plans for future patients.
- What could go wrong
- Because this is an observational registry study, it cannot prove cause and effect. Results may take many years to emerge, and the findings might not apply to all patients or treatment settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University hospital
RECRUITINGAarhus, Denmark
-
Centre Régional François Baclesse
RECRUITINGCaen, France
-
Gustave Roussy
RECRUITINGVillejuif, France
-
KU Leuven
RECRUITINGLeuven, Belgium
-
University Hospital Essen, The West German Proton Therapy Centre Essen
RECRUITINGEssen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a simple text message transform cancer care?
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
- DNA-Guided prescribing may shield young cancer patients from harmful drug reactions